Development of dual Nav1.1/1.7 inhibitors for the treatment of IBS-related pain (2018-2019)

Experts

Professor Glenn King

NHMRC Leadership Fellow and Group Leader: Institute for Molecular Bioscience

Affiliate of Centre for Cardiovascular Health and Research: Centre for Cardiovascular Health and Research; Faculty of Health, Medicine and Behavioural Sciences

Affiliate of Centre for Innovation in Pain and Health Research (CIPHeR): Centre for Innovation in Pain and Health Research; Faculty of Health, Medicine and Behavioural Sciences

Affiliate Professor of School of Chemistry and Molecular Biosciences: School of Chemistry and Molecular Biosciences; Faculty of Science

Affiliate of The Centre for Chemistry and Drug Discovery: Centre for Chemistry and Drug Discovery; Institute for Molecular Bioscience

Affiliate of ARC COE for Innovations in Peptide and Protein Science: ARC COE for Innovations in Peptide and Protein Science; Institute for Molecular Bioscience

Glenn King

Glenn King

Dr Fernanda Cardoso

Affiliate of Centre for Motor Neuron Disease Research: Centre for Motor Neuron Disease Research; Faculty of Health, Medicine and Behavioural Sciences

Affiliate of Centre for Innovation in Pain and Health Research (CIPHeR): Centre for Innovation in Pain and Health Research; Faculty of Health, Medicine and Behavioural Sciences

Senior Research Fellow: Institute for Molecular Bioscience

Fernanda Cardoso

Fernanda Cardoso